Nová a starsí farmaka ovlivnující inzulinovou sekreci
[New and older pharmaceuticals influencing insulin secretion]
Vnitrni lekarstvi.
2009 Apr ;
55 (4) :
421-4.
Language Czech Country Czech Republic Media print
Document type Journal Article
Persistent link
https://www.medvik.cz/link/pmid19449762
PubMed
19449762
- MeSH
- Diabetes Mellitus, Type 2 drug therapy physiopathology MeSH
- Glucagon-Like Peptide 1 pharmacology therapeutic use MeSH
- Glucose metabolism MeSH
- Incretins pharmacology therapeutic use MeSH
- Insulin metabolism MeSH
- Humans MeSH
- Insulin Secretion MeSH
- Sulfonylurea Compounds pharmacology therapeutic use MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Glucagon-Like Peptide 1 MeSH
- Glucose MeSH
- Incretins MeSH
- Insulin MeSH
- Sulfonylurea Compounds MeSH
The author briefly recapitulates the physiology of insulin secretion and pathophysiology with type II diabetes mellitus. Besides sulfonylurea secretagogues and glinides practically used in the long term, the author points out new possibilities of influencing insulin secretion by way of incretin mimetics and gliptins.
